Business Description
NextGen Healthcare Inc
NAICS : 621610
SIC : 8099
ISIN : US65343C1027
Description
NextGen Healthcare Inc is a United States-based company that provides healthcare solutions. The company offers technology and services platform supports for ambulatory and specialty practices of all sizes. It provides software, services, and analytics solutions to medical and dental group practices.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.73 | |||||
| Equity-to-Asset | 0.49 | |||||
| Debt-to-Equity | 0.65 | |||||
| Debt-to-EBITDA | 5.6 | |||||
| Interest Coverage | 0.61 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 3.61 | |||||
| Beneish M-Score | -2.62 | |||||
| WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 5.8 | |||||
| 3-Year EBITDA Growth Rate | -5 | |||||
| 3-Year EPS without NRI Growth Rate | -54.6 | |||||
| 3-Year FCF Growth Rate | -52.7 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 7 | |||||
| Future 3-5Y Total Revenue Growth Rate | 8 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 77.07 | |||||
| 9-Day RSI | 79.01 | |||||
| 14-Day RSI | 82.49 | |||||
| 6-1 Month Momentum % | 42.72 | |||||
| 12-1 Month Momentum % | 18.8 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.52 | |||||
| Quick Ratio | 2.52 | |||||
| Cash Ratio | 1.39 | |||||
| Days Sales Outstanding | 43.93 | |||||
| Days Payable | 12.07 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | 0.1 | |||||
| Shareholder Yield % | -16.12 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 46.4 | |||||
| Operating Margin % | 1.06 | |||||
| Net Margin % | -0.89 | |||||
| FCF Margin % | -6.24 | |||||
| ROE % | -1.48 | |||||
| ROA % | -0.75 | |||||
| ROIC % | 11.9 | |||||
| ROC (Joel Greenblatt) % | 113.24 | |||||
| ROCE % | 1.75 | |||||
| Years of Profitability over Past 10-Year | 9 |
GF Value Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio without NRI | 32.13 | |||||
| Shiller PE Ratio | 126.32 | |||||
| PS Ratio | 2.31 | |||||
| PB Ratio | 3.8 | |||||
| Price-to-Tangible-Book | 95.76 | |||||
| EV-to-EBIT | 145.95 | |||||
| EV-to-EBITDA | 34.36 | |||||
| EV-to-Revenue | 2.42 | |||||
| EV-to-Forward-Revenue | 2.34 | |||||
| EV-to-FCF | -38.75 | |||||
| Price-to-Projected-FCF | 2.59 | |||||
| Price-to-Median-PS-Value | 1.18 | |||||
| Price-to-Graham-Number | 11.62 | |||||
| Earnings Yield (Greenblatt) % | 0.69 | |||||
| FCF Yield % | -2.7 | |||||
| Forward Rate of Return (Yacktman) % | -1.95 |
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers